Why Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket


  • Jounce Therapeutics, Inc. JNCE shares rose 36.8% to $1.45 in pre-market after the company confirmed receipt of unsolicited proposal from Concentra Biosciences to acquire 100% of the company for $1.80 per share subject to diligence and availability of at least $130m of cash and equivalents at closing.
  • HUB Cyber Security (Israel) Ltd. HUBC rose 15.5% to $1.93 in pre-market trading after gaining more than 10% on Tuesday. HUB Security received $4 million from PIPE Investors at $10 per share.
  • NeuroOne Medical Technologies Corporation NMTC rose 15.2% to $1.81 in pre-market trading after gaining around 5% on Tuesday.
  • TC Biopharm (Holdings) Plc TCBP rose 14.1% to $3.49 in pre-market trading.
  • Loyalty Ventures Inc. LYLT rose 13.2% to $0.1924 in pre-market trading after dipping 23% on Tuesday.
  • Smartsheet Inc. SMAR rose 11.2% to $42.61 in pre-market trading after the company reported better-than-expected Q4 results and issued strong EPS guidance.
  • Ambipar Emergency Response AMBI rose 10.5% to $13.54 in pre-market trading after jumping around 117% on Tuesday.
  • Elevation Oncology, Inc. ELEV rose 9.8% to $1.57 in pre-market trading after jumping around 29% on Tuesday.
  • Kingsoft Cloud Holdings Limited KC rose 8.6% to $4.43 in pre-market trading.


  • Inpixon INPX fell 41.9% to $0.41 in pre-market. Inpixon completed distribution and business combination of CXApp Holding Corp. with KINS Technology Group Inc.
  • Boxed, Inc. BOXD fell 38.8% to $0.26 in pre-market trading. Boxed is negotiating with lenders for bankruptcy sale, the Wall Street Journal reported.
  • Celyad Oncology SA CYAD shares fell 25.1% to $0.7199 in pre-market trading. Celyad Oncology booked €35.1 million in goodwill and intangible impairment in FY22.
  • Credit Suisse Group AG CS fell 22.3% to $1.95 in pre-market trading. Saudi Arabia's SNB said it cannot give more money to Credit Suisse because cannot go above 10% ownership due to regulatory issue.
  • Intelligent Bio Solutions Inc. INBS fell 19.5% to $2.21 in pre-market trading. Intelligent Bio Solutions recently announced pricing of a $2.2 million public offering.
  • Vacasa, Inc. VCSA fell 13.7% to $1.13 in pre-market trading after reporting Q4 results.
  • Quoin Pharmaceuticals, Ltd. QNRX fell 12.1% to $0.4607 in pre-market trading. Quoin Pharmaceuticals recently posted a Q4 loss of $0.41 per share.
  • Elys Game Technology, Corp. ELYS shares dropped 10.5% to $0.51 in pre-market trading after surging 33% on Tuesday.
  • Merrimack Pharmaceuticals, Inc. MACK fell 10.3% to $10.50 in pre-market trading. Merrimack Pharmaceuticals recently posted a FY22 loss of $0.11 per share.
  • Lannett Company, Inc. LCI shares fell 10.1% to $1.60 in pre-market trading after declining over 4% on Tuesday. Lannett recently posted upbeat Q2 results.

Now Read This: Adobe Likely To Report Higher Quarterly Earnings - Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!